China NMPA Product Recall - Bone marrow biopsy needle

Vidacare Corporation, the manufacturer, initiated a global voluntary recall of its bone marrow biopsy needles, distributed by Teleflex Medical Devices Trading (Shanghai) Co., Ltd. The National Medical Products Administration (NMPA) published this recall on December 5, 2016, following Teleflex's report on November 10, 2016. The primary issue involved potential defects in the outer sterile packaging of the bone marrow biopsy needles (NMPA Registration Certificate No.: CFDA (Imported) No. 20143154576). This packaging flaw could compromise the sterility of the internal drape used for bone marrow aspiration preparation, thereby posing a risk of infection to patients. Under the NMPA's regulatory oversight, the recall was initiated globally. Crucially, Vidacare Corporation confirmed that the affected product batches were neither imported into nor sold in mainland China. Consequently, no specific corrective actions were required within China. However, the NMPA instructed provincial food and drug administrations to enhance supervision of such medical devices. The recall addresses a critical safety concern regarding medical device sterility.